Current practices concerning the assessment and treatment of lateral lymph nodes in low rectal cancer: a survey among colorectal surgeons in The Netherlands

References

• [cited 2021 Feb 1]. Available from: https://www.iknl.nl/nkr/cijfers-op-maat
   Google Scholar
• Kusters M, Marijnen CA, van de Velde CJ, et al. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol. 2010;36(5):470–476.
   PubMed Web of Science ®Google Scholar
• Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638–646.
   PubMed Web of Science ®Google Scholar
• Martling A, Holm T, Johansson H, et al. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer. 2001;92(4):896–902.
   PubMed Web of Science ®Google Scholar
• Iversen H, Martling A, Johansson H, et al. Pelvic local recurrence from colorectal cancer: surgical challenge with changing preconditions. Colorectal Dis. 2018;20(5):399–406.
   PubMed Web of Science ®Google Scholar
• Kim TH, Jeong SY, Choi DH, et al. Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol. 2008;15(3):729–737.
   PubMed Web of Science ®Google Scholar
• Steup WH, Moriya Y, van de Velde CJ. Patterns of lymphatic spread in rectal cancer. A topographical analysis on lymph node metastases. Eur J Cancer. 2002;38(7):911–918.
   PubMed Web of Science ®Google Scholar
• Kusters M, Beets GL, van de Velde CJ, et al. A comparison between the treatment of low rectal cancer in Japan and The Netherlands, focusing on the patterns of local recurrence. Ann Surg. 2009;249(2):229–235.
   PubMed Web of Science ®Google Scholar
• Ogura A, Konishi T, Cunningham C, et al. Neoadjuvant (chemo)radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: results of the multicenter lateral node study of patients with low cT3/4 rectal cancer. J Clin Oncol. 2019;37(1):33–43.
   PubMed Web of Science ®Google Scholar
• Ogura A, Konishi T, Beets GL, et al. Lateral nodal features on restaging magnetic resonance imaging associated with lateral local recurrence in low rectal cancer after neoadjuvant chemoradiotherapy or radiotherapy. JAMA Surg. 2019;154(9):e192172.
   PubMed Web of Science ®Google Scholar
• Akiyoshi T, Watanabe T, Miyata S, et al. Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease? Ann Surg. 2012;255(6):1129–1134.
   PubMed Web of Science ®Google Scholar
• Available from: https://cdn.ymaws.com/abdominalradiology.site-ym.com/resource/resmgr/education_dfp/rectal_cancer/sar_primary_rectal_cancer_st.pdf
   Google Scholar
• Beets-Tan RGH, Lambregts DMJ, Maas M, et al. Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol. 2018;28(4):1465–1475.
   PubMed Web of Science ®Google Scholar
• Kusters M, Slater A, Muirhead R, et al. What to do with lateral nodal disease in low locally advanced rectal cancer? A call for further reflection and research. Dis Colon Rectum. 2017;60(6):577–585.
   PubMed Web of Science ®Google Scholar
• Schaap DP, Ogura A, Nederend J, et al. Prognostic implications of MRI-detected lateral nodal disease and extramural vascular invasion in rectal cancer. Br J Surg. 2018;105(13):1844–1852.
   PubMed Web of Science ®Google Scholar
• Valentini V, Gambacorta MA, Barbaro B, et al. International consensus guidelines on clinical target volume delineation in rectal cancer. Radiother Oncol. 2016;120(2):195–201.
   PubMed Web of Science ®Google Scholar
• Yahya JB, Herzig DO, Farrell MJ, et al. Does a fine line exist between regional and metastatic pelvic lymph nodes in rectal cancer-striking discordance between national guidelines and treatment recommendations by US radiation oncologists. J Gastrointest Oncol. 2018;9(3):441–447.
   PubMed Web of Science ®Google Scholar
• Hartvigson PE, Apisarnthanarax S, Schaub S, et al. Radiation therapy dose escalation to clinically involved pelvic sidewall lymph nodes in locally advanced rectal cancer. Adv Radiat Oncol. 2019;4(3):478–486.
   PubMedGoogle Scholar
• Chen H, Nguyen KNB, Huang H, et al. Effect and safety of radiation therapy boost to extramesorectal lymph nodes in rectal cancer. Pract Radiat Oncol. 2020;10(5):e372–e377.
   PubMed Web of Science ®Google Scholar
• Fujita S, Mizusawa J, Kanemitsu Y, et al. Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): a multicenter, randomized controlled, noninferiority trial. Ann Surg. 2017;266(2):201–207.
   PubMed Web of Science ®Google Scholar
• Wei M, Wu Q, Fan C, et al. Lateral pelvic lymph node dissection after neoadjuvant chemo-radiation for preoperative enlarged lateral nodes in advanced low rectal cancer: study protocol for a randomized controlled trial. Trials. 2016;17(1):561.
   PubMedGoogle Scholar
• Konishi T, Shinozaki E, Murofushi K, et al. Phase II trial of neoadjuvant chemotherapy, chemoradiotherapy, and laparoscopic surgery with selective lateral node dissection for poor-risk low rectal cancer. Ann Surg Oncol. 2019;26(8):2507–2513.
   PubMed Web of Science ®Google Scholar
• Kim YI, Jang JK, Park IJ, Park SH, et al. Lateral lymph node and its association with distant recurrence in rectal cancer: a clue of systemic disease. Surgical Oncology. 2020;35:174–181.
   PubMed Web of Science ®Google Scholar
• Yang X, Yang S, Hu T, et al. What is the role of lateral lymph node dissection in rectal cancer patients with clinically suspected lateral lymph node metastasis after preoperative chemoradiotherapy? A meta-analysis and systematic review. Cancer Med. 2020;9(13):4477–4489.
   PubMed Web of Science ®Google Scholar
• Fujita S, Akasu T, Mizusawa J, et al. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Lancet Oncol. 2012;13(6):616–621.
   PubMed Web of Science ®Google Scholar
• Ito M, Kobayashi A, Fujita S, et al. Urinary dysfunction after rectal cancer surgery: results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan clinical oncology group study, JCOG0212). Eur J Surg Oncol. 2018;44(4):463–468.
   PubMed Web of Science ®Google Scholar
• Saito S, Fujita S, Mizusawa J, et al. Male sexual dysfunction after rectal cancer surgery: results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan clinical oncology group study JCOG0212. Eur J Surg Oncol. 2016;42(12):1851–1858.
   PubMed Web of Science ®Google Scholar